News
IVBXF
10.35
-2.36%
-0.25
Analysts Offer Insights on Healthcare Companies: Innovent Biologics (OtherIVBXF), Jazz Pharmaceuticals (JAZZ) and Inspire Medical Systems (INSP)
TipRanks · 1d ago
Innovent Biologics (IVBXF) Receives a Buy from Huatai Securities
TipRanks · 2d ago
Innovent Biologics Posts Strong Q3 Revenue Growth as Global Expansion Strategy Accelerates
TipRanks · 6d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 10/28 05:20
Innovent reports cancer drug results in breast, lung, pancreatic tumors
Seeking Alpha · 10/26 03:56
Innovent Biologics presents Phase 2 data for IBI354 at ESMO Congress
TipRanks · 10/25 21:20
Innovent Biologics (IVBXF) Gets a Buy from UBS
TipRanks · 10/21 00:25
CMB International Securities Keeps Their Buy Rating on Innovent Biologics (IVBXF)
TipRanks · 10/19 12:35
Innovent Wins China Approval for Jaypirca in All Lines of CLL/SLL Therapy
TipRanks · 09/28 10:40
Innovent Biologics announces China NMPA approves Jaypirca for new indication
TipRanks · 09/28 10:35
Innovent Biologics announces expansion of global Phase 3 MarsLight-11 trial
TipRanks · 09/28 00:45
Bernstein Sticks to Its Buy Rating for Innovent Biologics (IVBXF)
TipRanks · 09/24 06:45
Citic Securities Sticks to Its Buy Rating for Innovent Biologics (IVBXF)
TipRanks · 09/19 00:27
Nuvation Bio rises on FDA label update for Ibtrozi
Seeking Alpha · 09/17 12:32
Analysts Offer Insights on Healthcare Companies: Innovent Biologics (OtherIVBXF) and Definium Therapeutics (DFTX)
TipRanks · 09/14 15:10
Huatai Securities Sticks to Their Buy Rating for Innovent Biologics (IVBXF)
TipRanks · 09/13 05:15
UBS Keeps Their Buy Rating on Innovent Biologics (IVBXF)
TipRanks · 09/04 00:26
BOCOM International Holdings Company Reaffirms Their Buy Rating on Innovent Biologics (IVBXF)
TipRanks · 09/03 05:06
Innovent Biologics Details Board and Committee Structure
TipRanks · 09/01 12:38
Analysts Are Bullish on Top Healthcare Stocks: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990), Innovent Biologics (IVBXF)
TipRanks · 08/30 09:01
More
Webull provides a variety of real-time IVBXF stock news. You can receive the latest news about Innovent Biologi through multiple platforms. This information may help you make smarter investment decisions.
About IVBXF
Innovent Biologics Inc is an investment holding company principally engaged in the research, development, production and sales of innovative medicines for the treatment of diseases such as cancer, cardiovascular and metabolic (CVM), autoimmune and eye diseases. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The Company mainly conducts its businesses within domestic and overseas markets.